DocGo Announces Strong Third Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq set to open higher as CPI, bank earnings take focus; IBM tumbles
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Needham & Company Reiterates Buy Rating on DocGo (DCGO) Following 'Beat and Raise'
November 8, 2022 7:02 AM ESTNeedham & Company analyst Ryan MacDonald reiterated a Buy rating and $14.00 price target on DocGo (NASDAQ: DCGO) following Q3 'beat and raise'.
The analyst commented, "We reiterate our Buy rating & $14 PT following DCGO's 3Q22 beat and raise. As of Sept, covid testing... More
